Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Senti Biosciences (SNTI) Shares Outstanding (2021 - 2025)

Senti Biosciences has reported Shares Outstanding over the past 5 years, most recently at $30.9 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 539.45% year-over-year to $30.9 million; the TTM value through Dec 2025 reached $30.9 million, up 539.45%, while the annual FY2025 figure was $30.9 million, 539.45% up from the prior year.
  • Shares Outstanding for Q4 2025 was $30.9 million at Senti Biosciences, up from $26.3 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $43.6 million in Q3 2022 and troughed at $2.9 million in Q1 2021.
  • A 5-year average of $12.6 million and a median of $4.6 million in 2023 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: skyrocketed 1387.68% in 2022 and later tumbled 89.81% in 2023.
  • Year by year, Shares Outstanding stood at $3.0 million in 2021, then soared by 48.23% to $4.4 million in 2022, then increased by 3.72% to $4.6 million in 2023, then increased by 5.67% to $4.8 million in 2024, then surged by 539.45% to $30.9 million in 2025.
  • Business Quant data shows Shares Outstanding for SNTI at $30.9 million in Q4 2025, $26.3 million in Q3 2025, and $26.2 million in Q2 2025.